Osseo IQ
Chapter 1 · Foundations · §1.8

Wound Healing & the Blood Clot

How a wound seals, cleans, and rebuilds — and why, on an implant, the fibrin clot becomes the scaffold along which bone is laid down on the surface.

Compiled by
Tan Khuu, DDS
Licensed dentist (CA & SC)
Audience
Oral surgeons, prosthodontists, periodontists & residents
Edition
1.0 · June 2026
Reviewed
June 2026 · next review June 2027
Reading time
~16 minutes
Evidence basis
Foundational reviews + primary histology + consensus
§1.8.1 — Overview

The wound that learns to build bone

Every implant is placed into a wound, and the body answers an osteotomy the way it answers any other injury — with the same ancient, conserved repair cascade it would mount in skin or muscle. What makes the peri-implant wound special is not a different biology but a different endpoint: instead of resolving in a fibrous scar, this wound, given a receptive titanium surface, resolves in bone bonded directly to that surface. The pivot on which that special outcome turns is the humble blood clot. The fibrin meshwork that fills the gap between bone and implant in the first minutes is not merely a plug to stop bleeding; it is the provisional scaffold along which osteogenic cells crawl to reach the implant and lay bone upon it.1

This chapter traces the four overlapping phases of repair — hemostasis, inflammation, proliferation, and remodeling — and then maps each one onto what is happening at the implant surface during the same window. Two ideas recur and are worth fixing from the outset. First, the phases overlap rather than run in strict sequence; the clot is still being remodeled while granulation tissue forms, and woven bone is already mineralizing while inflammation resolves. Second, the clot is load-bearing in a biological sense — its retention on the implant surface is the single event that decides whether bone forms on the implant (contact osteogenesis) or merely advances toward it from the host walls (distance osteogenesis).2

The blood clot is not debris to be cleared on the way to healing; on an implant it is the cable along which bone is built.
◆ Key concept · One cascade, two destinations

Soft tissue and bone repair through the same four-phase cascade. In soft tissue the proliferative phase yields granulation tissue and the remodeling phase yields a collagenous scar. In the peri-implant wound the proliferative phase yields osteoconduction and de novo bone formation on the surface, and the remodeling phase replaces disorganized woven bone with load-bearing lamellar bone. The difference is the destination tissue — bone, not scar — and the decisive variable is whether the fibrin scaffold stays anchored to the implant.

§1.8.2 — The cascade

Four overlapping phases of healing

The figure below maps the four phases against a (non-linear) time axis from the moment of placement to roughly one year. Read it vertically to see which processes are co-active at any instant, and horizontally to follow a single phase from onset to resolution. Note how heavily the early events overlap: hemostasis is still resolving while inflammation peaks, and angiogenesis is well underway before the proliferative phase has handed off to remodeling.

minutes day 1 day 7 wk 2 wk 6 3 mo 1 yr 1 · Hemostasis fibrin clot anchors to surface 2 · Inflammation debridement · cell recruitment 3 · Proliferation osteoconduction · de novo bone 4 · Remodeling woven → lamellar · contact osteogenesis matures Angiogenesis Neutrophils Macrophages (M1→M2) Bar length ≈ duration of meaningful activity. Time axis is non-linear (compressed at right). Phases overlap by design; timeframes are slower in soft, grafted, or compromised sites.
Figure 1. The four overlapping phases of peri-implant wound healing from placement to one year, with the corresponding implant-surface event noted beside each phase. The fibrin clot of hemostasis is the scaffold that converts ordinary repair into osteoconduction; remodeling converts woven bone into load-bearing lamellar bone. Adapted from Davies' model of peri-implant endosseous healing.12

Phase 1 — Hemostasis and the fibrin clot

Within seconds of the osteotomy, vasoconstriction limits blood loss and a platelet plug forms over the cut surfaces. The coagulation cascade then converts soluble fibrinogen to insoluble fibrin, polymerizing a three-dimensional meshwork that fills the gap between bone and implant. This clot does two jobs at once. It seals the wound, and it serves as a growth-factor depot: activated platelets degranulate, releasing PDGF and TGF-β (along with VEGF and fibronectin) that will direct the cells of every subsequent phase.1 At the implant, the decisive event is that the fibrin scaffold adheres to the surface. The micro-topography and wettability of modern titanium are engineered precisely so that fibrin attaches and is retained against the retractile forces of migrating cells — because that retained scaffold is the cable along which osteogenic cells will travel.2

Phase 2 — Inflammation

Over days one to seven the wound is cleaned and the next phase is orchestrated. Neutrophils arrive first, dominating the first 24–48 hours and clearing bacteria and debris. Macrophages follow; they debride and, more importantly, signal — releasing cytokines and growth factors that recruit fibroblasts and osteogenic progenitor cells toward the wound bed. The macrophage population transitions over this window from a pro-inflammatory M1 phenotype to a pro-regenerative M2 phenotype, the switch that licenses angiogenesis and tissue rebuilding.3 Inflammation is necessary, but it must resolve on schedule: a prolonged or excessive inflammatory phase — as with smoking, infection, or poorly controlled diabetes — delays the recruitment of repair cells and stalls everything downstream.

Phase 3 — Proliferation: granulation, angiogenesis, and de novo bone

From roughly day three onward, new tissue is built. Granulation tissue fills the defect and angiogenesis — the sprouting of new capillaries — delivers the oxygen and nutrients without which no new tissue, least of all bone, can be made. Fibroblasts lay down a provisional connective-tissue matrix. At the implant this is the pivotal window, where ordinary repair diverges into osseointegration through two linked events described in Davies' model. In osteoconduction, osteogenic cells migrate across the retained fibrin scaffold to reach the implant surface itself. Having arrived, they perform de novo bone formation: they secrete a mineralized, collagen-poor interfacial matrix — the cement line — and then woven bone directly on the surface. Osteoconduction plus de novo formation is what we call contact osteogenesis, and on an appropriate surface it culminates in bone bonding.12

Phase 4 — Remodeling and maturation

Over weeks to a year the initial repair is reorganized into mature, load-bearing tissue. Disorganized, mechanically weak woven bone is replaced by lamellar bone through coupled osteoclast–osteoblast activity that refines architecture along load lines; the matrix mineralizes further and strength rises over months. Clinically, this maturation is what underlies the slow rise in secondary (biological) stability after placement. De novo alveolar bone laid against the implant during proliferation matures here into the intimate, bonded bone-to-implant contact that defines a successfully integrated implant.3

✦ Clinical pearl · Protect the clot, protect integration

Because the fibrin scaffold is the cable for osteogenic cell migration, every surgical choice that preserves it preserves contact osteogenesis. Atraumatic technique, adequate bleeding to seed a clot, primary stability so micromotion does not shear the clot from the surface, and a wettable surface that resists clot retraction all defend the same structure. Over-irrigation that flushes the clot, or a loose cover screw that pumps fluid across the surface, works directly against it.

▲ Common pitfalls
  • Treating the clot as disposable — aggressive curettage or irrigation that detaches fibrin from the surface forces bone to form at a distance instead of on the implant.
  • Ignoring a prolonged inflammatory phase. In smokers and uncontrolled diabetics the M1→M2 transition stalls; loading on the calendar rather than the biology loads an unhealed site.
  • Assuming the phases are sequential. Because they overlap, an insult in one phase (e.g. infection during inflammation) ripples forward into proliferation and remodeling.
§1.8.3 — Quick reference

Phase, timeframe, and the event at the implant

The table below condenses the cascade. Timeframes are approximate and overlap; they are slower in soft, grafted, or compromised sites. The right-hand column links each phase to the peri-implant event described in Davies' model, with an evidence grade for the strength of support behind each mapping.

Table 1 · The four phases of healing mapped to the implant surface
PhaseTimeframeKey cells / eventsAt the implant surfaceEvidence
HemostasisMinutes – hoursPlatelets, fibrin clot, PDGF / TGF-β releaseFibrin scaffold adheres to surfaceFoundational review
InflammationDays 1–7Neutrophils then macrophages (M1→M2); debridement & signalingClot retained; progenitor cells recruitedFoundational review
ProliferationDays 3–14+Fibroblasts, angiogenesis, granulation tissue, woven boneHistology Osteoconduction + de novo bonePreclinical
RemodelingWeeks – 1 yearCoupled osteoclasts / osteoblasts; woven → lamellar boneContact osteogenesis matures; bone bondingPreclinical

Phase explorer

Select any phase to review its dominant cells, molecular events, and — where relevant — what is happening at the implant surface during that window. On an implant, hemostasis and proliferation map directly onto osteoconduction and de novo bone formation.

Tap a phase to expand.

§1.8.4 — Glossary

Key terms

Hemostasis
The first phase of healing: vasoconstriction and a platelet plug, followed by conversion of fibrinogen to fibrin to form the clot that seals the wound.
Fibrin scaffold
The three-dimensional fibrin meshwork of the clot; on an implant it adheres to the surface and serves as the cable along which osteogenic cells migrate.
Osteoconduction
Migration of osteogenic cells across the fibrin / implant surface to reach the implant, the first of Davies' two healing phases.
De novo bone formation
Secretion by osteogenic cells of a mineralized cement-line matrix and woven bone directly on the implant surface.
Contact osteogenesis
The combined result of osteoconduction and de novo bone formation: new bone forming on the implant surface itself, leading to bone bonding.
Granulation tissue
The vascular, fibroblast-rich provisional tissue of the proliferative phase that fills a defect before mature tissue forms.
§1.8.S — Self-test

Self-Test

1. In the first minutes to hours after implant placement, the structure that adheres to the implant surface and becomes the scaffold for osteogenic cell migration is the:
A is correct. Hemostasis converts fibrinogen to fibrin, forming a clot that adheres to the implant surface. This fibrin scaffold is the cable along which osteogenic cells migrate (osteoconduction); granulation tissue, woven/lamellar bone, and the cement line all come later.
2. In Davies' model of peri-implant healing, osteogenic cells migrating across the fibrin/implant surface to reach and lay down bone directly on it describes:
B is correct. Osteoconduction is the migration of osteogenic cells across the fibrin scaffold to the surface; those cells then secrete matrix and form bone directly on the implant — contact osteogenesis. Distance osteogenesis lays bone from the old bone wall toward the implant.
3. During the proliferative phase, which event is essential because it delivers the oxygen and nutrients that allow new tissue to be built in the defect?
C is correct. Angiogenesis brings new capillaries that supply oxygen and nutrients to granulation tissue, enabling fibroblast matrix deposition and de novo bone formation. Vasoconstriction is hemostatic; neutrophils dominate inflammation; osteoclastic remodeling occurs in the final phase.
4. A heavy smoker shows delayed osseointegration. The phase whose prolongation most plausibly stalls every downstream healing event is the:
B is correct. A prolonged or excessive inflammatory phase (smoking, infection) delays recruitment of fibroblasts and osteogenic progenitors and pushes back proliferation and remodeling. Because the phases overlap and depend on one another, stalling inflammation delays everything downstream.
5. Which growth factors are released from activated platelets, making the clot a "growth-factor depot"?
B is correct. Activated platelets degranulate to release PDGF and TGF-β (with VEGF and fibronectin), which direct the cells of subsequent phases. RANKL/OPG govern osteoclastogenesis later; sclerostin and cathepsin K are remodeling-phase molecules.
6. The correct ordering of the four overlapping phases of wound healing is:
B is correct. The conserved cascade runs hemostasis, then inflammation, then proliferation, then remodeling. The phases overlap rather than run in strict sequence, but their onset follows this order.
7. Which cell type arrives first at the wound during the inflammatory phase?
C is correct. Neutrophils dominate the first 24–48 hours, clearing bacteria and debris, before macrophages arrive to debride and signal. Fibroblasts and osteoblasts belong to the proliferative phase; osteoclasts to remodeling.
8. The macrophage phenotype switch that licenses angiogenesis and tissue rebuilding is best described as:
B is correct. Macrophages transition from a pro-inflammatory M1 phenotype to a pro-regenerative M2 phenotype, which promotes resolution of inflammation and enables fibroblast and progenitor migration. A stalled M1→M2 switch impairs the entire downstream cascade.
9. Which structure does de novo bone formation produce that is equivalent to the cement line of natural bone?
B is correct. De novo bone formation deposits a mineralized, largely collagen-free interfacial matrix equivalent to the cement line, secreted directly on the implant before woven bone follows. A fibrous capsule represents failed integration.
10. Distance osteogenesis differs from contact osteogenesis in that bone:
B is correct. In distance osteogenesis bone forms from the old bone walls and grows toward the implant, so the surface is reached last. Contact osteogenesis forms bone on the surface itself, producing earlier, more intimate bone-to-implant contact.
11. The rise in secondary (biological) stability after placement is clinically attributable to which phase?
D is correct. Remodeling replaces woven bone with mechanically superior lamellar bone via coupled osteoclast–osteoblast activity, and ongoing mineralization raises strength over months — the basis of the rise in secondary stability. Proliferation deposits the initial woven bone but maturation drives the strength gain.
12. Why is moderate surface roughness and hydrophilicity engineered into modern implants in the context of clot biology?
B is correct. A moderately rough, wettable surface holds the fibrin scaffold and resists its retraction as cells migrate, favoring osteoconduction and contact osteogenesis. If the clot detaches, bone forms at a distance instead.
13. The approximate timeframe of the remodeling/maturation phase is:
D is correct. Remodeling begins around week three and can continue for up to a year, replacing woven with lamellar bone. Hemostasis is minutes–hours, inflammation days 1–7, and proliferation days 3–14+.
14. Which statement about the overlap of healing phases is most accurate?
B is correct. The phases overlap rather than run strictly in sequence; angiogenesis of proliferation is underway while inflammation is still resolving, and woven bone mineralizes before inflammation fully clears.
15. The two healing phases that, in Davies' model, together produce contact osteogenesis are:
B is correct. Davies describes osteoconduction (cell migration to the surface) followed by de novo bone formation (matrix deposition on the surface); together they yield contact osteogenesis and, on an appropriate surface, bone bonding.
16. Excessive micromotion at the interface most directly threatens osseointegration during early healing because it:
B is correct. If micromotion shears the fibrin scaffold off the surface, osteogenic cells cannot migrate to the implant, bone forms at a distance, and fibrous encapsulation may follow instead of integration. Primary stability limits this micromotion.
17. Which cells deposit the provisional connective-tissue matrix during the proliferative phase?
C is correct. Fibroblasts migrate into the wound during proliferation and lay down provisional connective-tissue matrix within the granulation tissue. Neutrophils and platelets act earlier; osteoclasts act in remodeling.
18. Woven bone is best characterized, relative to lamellar bone, as:
B is correct. Woven bone is laid down quickly and is disorganized and mechanically weak; remodeling replaces it with organized, load-bearing lamellar bone, raising secondary stability over time.
19. The primary purpose of vasoconstriction at the very start of healing is to:
B is correct. Vasoconstriction is an early hemostatic event that limits blood loss while the platelet plug forms and the coagulation cascade builds the fibrin clot. Osteogenic and macrophage events come later.
20. Surgically, the single most important reason to preserve the blood clot on the implant surface is that it:
B is correct. The clot is the scaffold along which osteogenic cells migrate to the surface; if it detaches, bone forms at a distance and intimate bone-to-implant contact is delayed. Primary stability is mechanical and separate; the clot's role is biological.
1. Walk the examiner through the four phases of wound healing and map them onto what is happening at the implant surface.
Model answer. The phases overlap rather than run strictly in sequence. (1) Hemostasis (minutes–hours): vasoconstriction then a platelet plug; the coagulation cascade converts fibrinogen to fibrin, forming a clot that is also a growth-factor depot (PDGF, TGF-β). At the implant, this fibrin scaffold adheres to the surface. (2) Inflammation (days 1–7): neutrophils then macrophages debride and signal, with an M1→M2 switch that recruits fibroblasts and osteogenic progenitors. (3) Proliferation (days 3–14+): granulation tissue and angiogenesis; osteogenic cells migrate across the fibrin to the surface (osteoconduction) and lay down a mineralized cement-line matrix and woven bone — contact osteogenesis. (4) Remodeling (weeks–a year): woven bone is replaced by lamellar bone via coupled osteoclast–osteoblast activity, underlying the rise in secondary stability.
Examiner follow-ups:
  • Which growth factors does the clot release and from where?
  • Where does osteoconduction sit in this timeline?
  • How does this map onto primary vs secondary stability?
2. Compare contact osteogenesis and distance osteogenesis, and justify why surface design favors the former.
Model answer. In contact osteogenesis, osteogenic cells migrate across the fibrin scaffold to reach the implant and form new bone directly on the surface (de novo), so mineralization proceeds outward from the surface toward the old bone. In distance osteogenesis, bone forms from the existing bone walls and grows toward the implant, so the surface is reached last. Contact osteogenesis is preferred because it produces earlier, more intimate bone-to-implant contact. It depends on the fibrin clot staying anchored to the surface so cells can migrate along it; a moderately rough, wettable surface retains the clot and resists its retraction during cell migration, which is why surface topography and hydrophilicity are engineered to promote it.
Examiner follow-ups:
  • Why does clot retention favor contact osteogenesis?
  • How does surface roughness influence which mode dominates?
  • What is a cement line and what is its role?
3. Explain the role of the fibrin clot in osseointegration and defend why preserving it surgically matters.
Model answer. The fibrin clot does three jobs: it seals the wound, acts as a growth-factor depot releasing PDGF and TGF-β from activated platelets, and — critically at an implant — forms the provisional scaffold that adheres to the surface and along which osteogenic cells migrate to enable osteoconduction and contact osteogenesis. If the clot detaches or retracts from the surface during cell migration, cells cannot reach the implant and bone forms at a distance instead, delaying intimate bone-to-implant contact. Surgically, atraumatic technique, adequate bleeding to seed the clot, primary stability so micromotion does not shear the clot, and a wettable surface that holds the clot all protect this scaffold and therefore protect early integration.
Examiner follow-ups:
  • How does excessive micromotion disrupt the clot?
  • Why does surface wettability help clot adhesion?
  • What growth factors does the clot supply and what do they do?
4. A patient is a heavy smoker with poorly controlled diabetes. Explain, in terms of the healing phases, why you expect delayed and less predictable osseointegration.
Model answer. Both smoking and hyperglycemia chiefly disturb the inflammatory phase. Smoking causes vasoconstriction and tissue hypoxia and impairs neutrophil and macrophage function; uncontrolled diabetes prolongs a pro-inflammatory state and stalls the M1→M2 macrophage transition. Because the phases overlap and depend on one another, a prolonged or excessive inflammatory phase delays recruitment of fibroblasts and osteogenic progenitors, blunts angiogenesis, and therefore pushes back proliferation (osteoconduction and de novo bone) and remodeling. Hypoxia further limits the oxygen that angiogenesis must supply for new bone. Clinically I would optimize glycemic control, counsel smoking cessation, consider staged or delayed loading, and not load on the calendar alone.
Examiner follow-ups:
  • Which specific phase is the bottleneck and why?
  • How does the M1→M2 switch fit in?
  • How would these host factors change your loading protocol?
5. Define osteoconduction, de novo bone formation, and contact osteogenesis, and explain how they relate to one another and to bone bonding.
Model answer. These are the two sequential healing phases of Davies' model plus their combined outcome. Osteoconduction is the recruitment and migration of osteogenic cells to the implant surface through the residue of the peri-implant blood clot — the cells crawl along the retained fibrin scaffold. De novo bone formation is what those cells do on arrival: they secrete a mineralized, collagen-poor interfacial matrix equivalent to the cement line of natural bone, then woven bone, directly on the surface. Together, osteoconduction and de novo bone formation constitute contact osteogenesis — bone formed on the implant surface itself — and, given an appropriate surface, this culminates in bone bonding, the direct structural connection that defines osseointegration.
Examiner follow-ups:
  • What is the role of the fibrin scaffold in osteoconduction?
  • What is the cement line and why does it matter?
  • What surface properties make bone bonding more likely?
§1.8 — References

References

  1. Davies JE. Understanding peri-implant endosseous healing. J Dent Educ. 2003;67(8):932–949. PMID: 12959168
  2. Terheyden H, Lang NP, Bierbaum S, Stadlinger B. Osseointegration — communication of cells. Clin Oral Implants Res. 2012;23(10):1127–1135. doi:10.1111/j.1600-0501.2011.02327.x
  3. Berglundh T, Abrahamsson I, Lang NP, Lindhe J. De novo alveolar bone formation adjacent to endosseous implants. Clin Oral Implants Res. 2003;14(3):251–262. doi:10.1034/j.1600-0501.2003.00972.x

Evidence grades: Foundational review Consensus Preclinical / Histology.

About this chapter

This chapter is part of Osseo IQ — a clinical reference for implant dentistry. Content is sourced from consensus statements, systematic reviews, and primary literature; each key recommendation carries an evidence grade, and every page records its review date. Material is reviewed on a rolling annual cycle.

How to cite: Khuu T, ed. Wound Healing & the Blood Clot. In: Osseo IQ, 1st ed. §1.8. June 2026. Accessed [date]. [URL]

Compiled by: Tan Khuu, DDS — Doctor of Dental Surgery and a licensed dentist in California and South Carolina. Osseo IQ summarizes published evidence and clinical guidelines and is not a substitute for individual clinical judgment. Image credits: Figure 1 original schematic illustration © Osseo IQ, 2026.

For licensed clinicians — educational use only. This chapter summarizes published evidence and is not a substitute for individual clinical judgment, examination, or the standard of care in your jurisdiction. Verify drug doses, devices, and protocols against current manufacturer instructions and local guidelines.

© 2026 Osseo IQ · Edition 1.0 · Chapter 1 Foundations · §1.8 · Last reviewed June 2026